1. Home
  2. SCYX vs FTCI Comparison

SCYX vs FTCI Comparison

Compare SCYX & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • FTCI
  • Stock Information
  • Founded
  • SCYX 1999
  • FTCI 2017
  • Country
  • SCYX United States
  • FTCI United States
  • Employees
  • SCYX N/A
  • FTCI N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • FTCI Semiconductors
  • Sector
  • SCYX Health Care
  • FTCI Technology
  • Exchange
  • SCYX Nasdaq
  • FTCI Nasdaq
  • Market Cap
  • SCYX 40.9M
  • FTCI 43.8M
  • IPO Year
  • SCYX 2014
  • FTCI 2021
  • Fundamental
  • Price
  • SCYX $0.90
  • FTCI $2.70
  • Analyst Decision
  • SCYX
  • FTCI Buy
  • Analyst Count
  • SCYX 0
  • FTCI 4
  • Target Price
  • SCYX N/A
  • FTCI $5.38
  • AVG Volume (30 Days)
  • SCYX 94.5K
  • FTCI 133.0K
  • Earning Date
  • SCYX 05-07-2025
  • FTCI 05-09-2025
  • Dividend Yield
  • SCYX N/A
  • FTCI N/A
  • EPS Growth
  • SCYX N/A
  • FTCI N/A
  • EPS
  • SCYX N/A
  • FTCI N/A
  • Revenue
  • SCYX $3,746,000.00
  • FTCI $47,355,000.00
  • Revenue This Year
  • SCYX $460.12
  • FTCI $107.93
  • Revenue Next Year
  • SCYX $253.87
  • FTCI $121.09
  • P/E Ratio
  • SCYX N/A
  • FTCI N/A
  • Revenue Growth
  • SCYX N/A
  • FTCI N/A
  • 52 Week Low
  • SCYX $0.73
  • FTCI $1.76
  • 52 Week High
  • SCYX $3.07
  • FTCI $7.40
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 45.97
  • FTCI 48.88
  • Support Level
  • SCYX $0.89
  • FTCI $2.52
  • Resistance Level
  • SCYX $0.99
  • FTCI $2.88
  • Average True Range (ATR)
  • SCYX 0.08
  • FTCI 0.38
  • MACD
  • SCYX 0.01
  • FTCI 0.02
  • Stochastic Oscillator
  • SCYX 64.71
  • FTCI 43.51

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

Share on Social Networks: